Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

This study has been completed.

Study NCT00086944 Information provided by National Cancer Institute (NCI)

First Received: July 8, 2004 Last Updated: April 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	July 2006 (Final data collection date for primary outcome measure)